WebDisclosure WebDisclosure
Basculer en Français
10320 Companies
213969 Keywords
143665 Articles
113262 Press releases
Headlines Articles Press releases Simcere Pharmaceutical Group Limited Remove
  1. Home
  2. Companies
  3. Simcere Pharmaceutical Group Limited
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 01/27/2026 at 12:00, 3 months 2 days ago

    Boehringer Ingelheim and Simcere Collaborate on IBD Treatment

    Immunology Boehringer Ingelheim Inflammatory Bowel Disease Bispecific Antibody Simcere Partnership
  • BRIEF

    published on 01/27/2026 at 12:00, 3 months 2 days ago

    Boehringer Ingelheim et Simcere collaborent sur le traitement des MII

    Boehringer Ingelheim Immunologie Maladie Inflammatoire De L'intestin Anticorps Bispécifique Partenariat Simcere
  • PRESS RELEASE

    published on 01/27/2026 at 11:55, 3 months 2 days ago

    Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease

    Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment for inflammatory bowel disease. SIM0709, a novel bispecific antibody, aims to improve outcomes for patients worldwide
    Boehringer Ingelheim Inflammatory Bowel Disease IBD Simcere Antibody Treatment
    Logo of Simcere Pharmaceutical Group Limited
Accesswire
  • Published on 04/29/2026 at 23:00, just now

    Silver Spruce Resources Inc. Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933

  • Published on 04/29/2026 at 22:10, 50 minutes ago

    International Battery Metals Announces Closing Of Previously Announced Fourth Follow-On Investment From EV Metals 9 LLC, Adding USD $2.8 Million Under Existing LOI

  • Published on 04/29/2026 at 22:01, 59 minutes ago

    Kidoz Inc. Reports Record Revenue of USD $18,433,172 (CAD $25,761,870) and Net Income of USD $456,817 (CAD $638,439) in Fiscal 2025

  • Published on 04/29/2026 at 19:37, 3 hours 23 minutes ago

    Alphinat Announces a Net Loss of $(166,109) for Quarter Ended February 28, 2026

  • Published on 04/29/2026 at 15:30, 7 hours 30 minutes ago

    Infield Minerals Announces Financing

View all ACCESSWIRE
EQS Group
  • Published on 04/29/2026 at 22:15, 45 minutes ago

    Amrize Grows Revenue 4.7% in First Quarter and Reaffirms 2026 Guidance

  • Published on 04/29/2026 at 22:05, 55 minutes ago

    Evotec Announces New Nomination to Board of Directors

  • Published on 04/29/2026 at 20:00, 3 hours ago

    Onlineprinters confirms FY 2025 results and provides outlook for 2026

  • Published on 04/29/2026 at 20:00, 3 hours ago

    lePERMISLIBRE met fin au contrat de liquidité confié à TP ICAP (Europe)

  • Published on 04/29/2026 at 19:45, 3 hours 15 minutes ago

    VAZIVA SA: FORTE PROGRESSION DES RESULTATS ANNUELS 2025 - PERSPECTIVES 2026

View all EQS
Les Echos
  • Published on 04/29/2026 at 18:31, 4 hours 29 minutes ago

    FIRST QUARTER 2026 TURNOVER

  • Published on 04/29/2026 at 18:31, 4 hours 29 minutes ago

    CHIFFRE D'AFFAIRES PREMIER TRIMESTRE 2026

  • Published on 04/29/2026 at 18:15, 4 hours 45 minutes ago

    GUILLEMOT CORPORATION | MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL INCLUANT LE RAPPORT FINANCIER ANNUEL 2025

  • Published on 04/29/2026 at 18:15, 4 hours 45 minutes ago

    GUILLEMOT CORPORATION | AVAILABILITY OF THE UNIVERSAL REGISTRATION DOCUMENT INCLUDING THE 2025 ANNUAL FINANCIAL REPORT

  • Published on 04/29/2026 at 18:10, 4 hours 50 minutes ago

    Amemdment of the resolution n8 submitted to the AGM of 30 April 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy